With the investment in research and development, many important products of Prenetics have made significant progress recently.
In June, Prenetics officially launched ColoClear, a non-invasive genetic test that detects early-stage colorectal cancer risk.
In August, Prenetics released the Circle Snapshot, a painless at-home blood test. The product can detect a number of indicators in the blood through painless blood collection, and evaluate the health risks of consumers in terms of food allergies, heart health, and new coronavirus antibodies.
In the fourth quarter of this year, Prenetics also plans to launch pet genetic testing products. By then, the company will have more products on the market, covering multiple testing and screening fields, and realizing an [end-to-end] healthy ecosystem from prevention to diagnosis to personalized care system.
Submitted October 19, 2022 at 03:10AM by Front_Bell_7616 https://ift.tt/PNVWtgM
